The trajectory of companies tied to Sildenafil's history presents a challenging investment scenario . While the initial boom generated substantial returns , generic copies have significantly diminished https://social-galaxy.com/story7192202/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-risky-investment